CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 74 filers reported holding CYTOSORBENTS CORP in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,414 | +117.4% | 2,200 | 0.0% | 0.00% | – |
| Q4 2022 | $3,410 | -93.9% | 2,200 | -70.2% | 0.00% | -100.0% |
| Q2 2021 | $56,000 | -5.1% | 7,380 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $59,000 | -3.3% | 7,380 | -3.9% | 0.00% | -33.3% |
| Q3 2020 | $61,000 | +38.6% | 7,680 | +35.2% | 0.00% | 0.0% |
| Q1 2020 | $44,000 | +266.7% | 5,680 | +83.8% | 0.00% | +200.0% |
| Q4 2019 | $12,000 | -47.8% | 3,090 | -11.7% | 0.00% | 0.0% |
| Q3 2019 | $23,000 | 0.0% | 3,500 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $23,000 | +109.1% | 3,500 | +133.3% | 0.00% | 0.0% |
| Q1 2019 | $11,000 | -56.0% | 1,500 | -76.8% | 0.00% | -85.7% |
| Q1 2016 | $25,000 | -30.6% | 6,460 | 0.0% | 0.01% | -41.7% |
| Q4 2015 | $36,000 | -12.2% | 6,460 | 0.0% | 0.01% | 0.0% |
| Q3 2015 | $41,000 | -2.4% | 6,460 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $42,000 | -14.3% | 6,460 | -3.0% | 0.01% | -14.3% |
| Q1 2015 | $49,000 | – | 6,660 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skylands Capital, LLC | 815,869 | $3,141,000 | 0.46% |
| Sargent Investment Group, LLC | 499,010 | $1,921,000 | 0.36% |
| Anson Funds Management LP | 74,440 | $287,000 | 0.33% |
| One68 Global Capital, LLC | 39,241 | $151,000 | 0.33% |
| Granahan Investment Management | 678,618 | $2,613,000 | 0.12% |
| Winning Points Advisors, LLC | 30,000 | $115,000 | 0.07% |
| Avenir Corp | 150,600 | $580,000 | 0.06% |
| HighMark Wealth Management LLC | 10,000 | $38,000 | 0.04% |
| Wealthcare Advisory Partners LLC | 62,279 | $240,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 64,970 | $250,000 | 0.03% |